Clinical Trials Browser

Phase 2 × NIH × Endometrial Hyperplasia × Clear all

NCT07349641 2026-03-17

A Study of Weight Loss Intervention With Tirzepatide and Progestin Intrauterine Device to Treat Endometrial Hyperplasia and Grade 1 Endometrial Cancer

Phase 2 Not yet recruiting

Endometrial Hyperplasia

NCT03300557 2025-08-29

Exemestane in Treating Patients With Complex Atypical Hyperplasia of the Endometrium/Endometrial Intraepithelial Neoplasia or Low Grade Endometrial Cancer

Phase 2 Completed

40 enrolled 13 charts

Endometrial Hyperplasia, Endometrial Neoplasms